1/58
Looks like no tags are added yet.
"Define sleep apnea and its main characteristics."
"Sleep apnea is a chronic sleep disorder characterized by repeated pauses in breathing (lasting more than 10 seconds) or shallow breaths during sleep, leading to sleep disruption, fatigue, and daytime somnolence."
"Explain the difference between obstructive sleep apnea (OSA) and central sleep apnea (CSA)."
"Obstructive sleep apnea (OSA) is caused by the collapse of upper airway soft tissues during sleep despite respiratory effort, leading to obstructive apneas and hypopneas. Central sleep apnea (CSA) is less common and occurs when the brain fails to send signals to the muscles of respiration, resulting in airflow limitation without respiratory effort."
"Describe the characteristics of mixed sleep apnea."
"Mixed sleep apnea features respiratory events that begin as central apneas and transition into obstructive apneas."
"Identify the primary risk factor for the development of obstructive sleep apnea (OSA)."
"Obesity, defined as a body mass index (BMI) of 30 kg/m² or higher, is the primary risk factor strongly correlated with the development of obstructive sleep apnea."
"List demographic and genetic risk factors associated with sleep apnea."
"Risk factors include male sex, advanced age (over 65 years), positive family history, sedentary lifestyle, and certain genetic syndromes."
"Explain how anatomical and craniofacial abnormalities contribute to sleep apnea."
"Anatomical and craniofacial abnormalities such as mandibular retrognathia, tonsillar hyperplasia, macroglossia, and hypertrophied pharyngeal muscles can obstruct the airway during sleep, increasing the risk of sleep apnea."
"Describe the significance of neck circumference in relation to sleep apnea risk."
"A thick neck circumference (≥17 inches in men and ≥16 inches in women) is strongly correlated with an increased risk of obstructive sleep apnea."
"Identify endocrine and neuromuscular factors that may contribute to sleep apnea."
"Factors include postmenopause in women, acromegaly (excess growth hormone), hypothyroidism (reduced metabolic rate), and poor pharyngeal muscle tone due to brain injury or neuromuscular disease."
"Explain the role of diagnostic evaluation in managing sleep apnea."
"Diagnostic evaluation for sleep apnea typically involves sleep studies to assess breathing patterns, oxygen levels, and sleep quality, which are crucial for determining the appropriate management strategies."
"Discuss the clinical presentation of sleep apnea."
"Clinical presentation of sleep apnea includes symptoms such as loud snoring, observed episodes of breathing cessation during sleep, excessive daytime sleepiness, fatigue, and difficulty concentrating."
"Describe the impact of alcohol intake and sedative-hypnotic medications on the central nervous system before sleep."
"Alcohol intake and sedative-hypnotic medications promote CNS depression and relax pharyngeal and tongue musculature, which can contribute to sleep-related breathing disorders."
"Explain the incidence of obstructive sleep apnea (OSA) in men and women."
"The incidence of OSA occurs in 20%–30% of men and 10%–15% of women, with postmenopausal women approaching the incidence rates of men."
"How does the prevalence of obstructive sleep apnea change with age and ethnicity?"
"Prevalence of OSA increases with age, plateauing after 65 years. African Americans, Native Americans, and Hispanics exhibit higher rates independent of age and BMI."
"Define the global impact of obstructive sleep apnea between 1990 and 2010."
"Global prevalence of OSA more than doubled due to increased detection and rising obesity rates during this period."
"What is the mortality risk associated with untreated severe obstructive sleep apnea?"
"Untreated severe OSA carries a 3- to 6-fold increased risk of all-cause mortality compared to non-affected individuals."
"Explain the pathophysiological mechanism of upper airway collapse during sleep."
"Sleep-induced muscle relaxation causes upper airway collapse, leading to apnea or hypopnea, which results in reduced airflow and subsequent pulmonary hypoxia and hypercapnia."
"Describe the role of sympathetic activation in obstructive sleep apnea."
"Hypercapnia and hypoxemia trigger sympathetic nervous system stimulation, increasing respiratory effort and causing transient tachycardia and systemic hypertension until the patient awakens."
"What are the vascular and cardiac complications associated with chronic nocturnal pulmonary hypoxia?"
"Chronic nocturnal pulmonary hypoxia can lead to pulmonary hypertension, right-sided heart failure (cor pulmonale), systemic hypertension, stroke, coronary artery disease, and other serious health issues."
"How do bed partners typically report symptoms of obstructive sleep apnea?"
"Bed partners often report loud, cyclical snoring, witnessed apneas, sudden breath cessation, nocturnal restlessness, and thrashing limb movements."
"List common patient-reported symptoms of obstructive sleep apnea."
"Common symptoms include excessive daytime sleepiness, morning headaches, nocturnal choking or gasping, frequent night awakenings, vivid dreams, nocturia, cognitive deficits, mood changes, and occupational impairment."
"Describe the physical examination signs associated with obesity in relation to sleep apnea."
"Obesity is indicated by a BMI ≥ 30 kg/m² and may present with a thick 'bull neck' contour."
"Explain the significance of the Mallampati class score in diagnosing oropharyngeal crowding."
"A high Mallampati class score (Class I to IV) indicates oropharyngeal crowding, which can include features like soft tissue mucosal folds, enlarged tonsils, macroglossia, retrognathia, or micrognathia."
"How does upper nasal pathway compromise affect sleep apnea diagnosis?"
"Upper nasal pathway compromise can be indicated by nasal mucosal obstruction, nasal polyps, or a deviated nasal septum, which may contribute to obstructive sleep apnea."
"Define the purpose of clinical questionnaires in the diagnostic evaluation of sleep apnea."
"Clinical questionnaires, such as the STOP-BANG questionnaire and the Epworth Sleepiness Scale, assess pretest probability and help identify risk factors for obstructive sleep apnea."
"What role does nocturnal oximetry play in sleep apnea screening?"
"Nocturnal oximetry is used as a screening tool; a normal study has a high negative predictive value to rule out obstructive sleep apnea."
"Describe the laboratory workup components for evaluating obstructive sleep apnea."
"The laboratory workup includes hemoglobin/hematocrit tests to check for secondary erythrocytosis and serum thyroid function tests (TSH and free T4) to rule out hypothyroidism."
"Explain the significance of polysomnography (PSG) in diagnosing obstructive sleep apnea."
"Polysomnography (PSG) is the gold-standard diagnostic test for obstructive sleep apnea, performed as an overnight study that monitors various physiological parameters."
"Define the Apnea/Hypopnea Index (AHI) and its relevance in staging obstructive sleep apnea."
"The Apnea/Hypopnea Index (AHI) categorizes the severity of obstructive sleep apnea: Mild (5 to <15 events/hour), Moderate (15 to 30 events/hour), and Severe (>30 events/hour or oxyhemoglobin saturation <90% for >20% of total sleep time)."
"What are the characteristics of mild obstructive sleep apnea?"
"Mild obstructive sleep apnea is characterized by an AHI of 5 to <15 events/hour, with patients often minimally symptomatic and without significant impairment in daily life."
"Describe the symptoms associated with moderate obstructive sleep apnea."
"Moderate obstructive sleep apnea, with an AHI of 15 to 30 events/hour, is associated with conscious daytime sleepiness, planned daytime naps, and reduced activity levels."
"What defines severe obstructive sleep apnea and its potential complications?"
"Severe obstructive sleep apnea is defined by an AHI >30 events/hour or oxyhemoglobin saturation <90% for >20% of total sleep time, leading to severe daytime somnolence and high risk for complications like cardiopulmonary failure."
"How can behavioral modifications aid in the management of obstructive sleep apnea?"
"Behavioral modifications, such as weight loss, exercise, and substance avoidance, are indicated for all patients with modifiable risk factors to improve airway dynamics."
"Explain the impact of weight loss on obstructive sleep apnea management."
"Achieving a 10%–20% weight reduction significantly improves airway dynamics and can alleviate symptoms of obstructive sleep apnea."
"What is the effect of exercise on obstructive sleep apnea independent of weight loss?"
"Exercise improves obstructive sleep apnea symptoms independently of weight loss, contributing to better overall respiratory function."
"Describe the importance of avoiding substances before bedtime for patients with obstructive sleep apnea."
"Strict avoidance of alcohol and sedative-hypnotic medications before bedtime is crucial to prevent pharyngeal muscle relaxation, which can exacerbate obstructive sleep apnea."
"Describe Positional Therapy for sleep apnea."
"Positional Therapy involves elevating the head of the bed, avoiding the supine sleeping position, and encouraging side-lying sleep to keep the tongue positioned forward."
"Explain the importance of Sleep Hygiene in managing sleep disorders."
"Sleep Hygiene includes maintaining consistent sleep schedules, sleeping in a dark room, limiting electronic devices, and restricting late-day caffeine, alcohol, and nicotine to promote better sleep quality."
"Define Continuous Positive Airway Pressure (CPAP) and its role in OSA treatment."
"CPAP is the most effective, first-line medical treatment for Obstructive Sleep Apnea (OSA), functioning as a pneumatic splint that delivers continuous positive pressure to keep the pharyngeal airway open."
"How does CPAP affect symptoms of OSA?"
"CPAP resolves symptoms such as snoring, restlessness, daytime somnolence, and cognitive deficits, but requires long-term compliance for effectiveness."
"What is Bilevel Positive Airway Pressure (BiPAP) and when is it used?"
"BiPAP delivers higher positive pressure during inhalation and lower pressure during exhalation, aiding patients who cannot tolerate high continuous CPAP pressures."
"Describe the function of Oral Appliances in OSA management."
"Oral Appliances are custom-designed dental devices that protrude the mandible forward or hold the tongue anteriorly, reducing event frequency in mild-to-moderate OSA."
"Explain the types of surgical interventions available for OSA."
"Surgical interventions for OSA include uvulopalatopharyngoplasty (UPPP), laser/radiofrequency ablation, septoplasty, tonsillectomy/adenoidectomy, maxillomandibular advancement, bariatric surgery, tracheotomy for severe cases, and hypoglossal nerve stimulation."
"What is the management approach for Central Sleep Apnea (CSA)?"
"Management of Central Sleep Apnea is complex and requires specialized referral to Sleep Medicine."
"Define obesity hypoventilation syndrome and its historical name."
"Obesity hypoventilation syndrome, historically referred to as Pickwickian syndrome, is characterized by excess adipose tissue accumulation that impairs normal mechanical ventilation."
"Identify the formal diagnostic criteria for obesity hypoventilation syndrome."
"The diagnostic criteria include obesity defined by a BMI > 40 kg/m², awake daytime hypercapnia with arterial PCO₂ > 45 mmHg while awake, and absence of primary lung disease or other disorders causing hypoventilation."
"Explain the pathogenesis of obesity hypoventilation syndrome."
"The exact pathogenesis of obesity hypoventilation syndrome remains incompletely understood, but it primarily involves excess adipose tissue accumulation in severely obese individuals."
"Describe the relationship between Obesity Hypoventilation Syndrome (OHS) and obstructive sleep apnea (OSA)."
"80% to 90% of patients diagnosed with OHS have co-existing OSA as shown on polysomnography."
"Explain how excess adipose tissue affects respiratory function in patients with OHS."
"Excess adipose tissue surrounding the chest wall and abdomen increases the work of breathing, decreases respiratory compliance, and restricts lung expansion."
"What are the consequences of persistent alveolar hypoventilation during wakefulness in OHS patients?"
"It results in chronic daytime hypercapnia (PCO₂ > 45 mmHg) and hypoxemia."
"How does chronic hypercapnia affect the kidneys in patients with OHS?"
"Chronic hypercapnia prompts renal retention of bicarbonate (HCO₃⁻) to compensate for ongoing respiratory acidosis."
"List the common symptoms experienced by patients with Obesity Hypoventilation Syndrome."
"Severe daytime hypersomnolence, chronic fatigue, exertional dyspnea, morning headaches, and cognitive slowing."
"Identify the physical exam signs indicative of Obesity Hypoventilation Syndrome."
"Severe obesity (BMI > 40 kg/m²), central adiposity, cyanosis, and signs of right heart strain or cor pulmonale (elevated JVD, peripheral edema)."
"What is the definitive laboratory test for diagnosing hypercapnia in OHS patients?"
"Arterial Blood Gas (ABG) test demonstrating daytime awake hypercapnia (PCO₂ > 45 mmHg) and hypoxemic gas exchange."
"How does an elevated serum bicarbonate level relate to chronic hypoventilation in obese patients?"
"It serves as a highly useful laboratory marker signaling underlying chronic hypoventilation."
"What role does polysomnography (PSG) play in the evaluation of OHS?"
"PSG is indicated to evaluate for co-existing obstructive sleep apnea, which is present in 80% to 90% of OHS patients."
"Describe the purpose of pulmonary function testing and chest imaging in the diagnostic evaluation of OHS."
"They are performed to exclude parenchymal lung disease, primary chest wall disorders, or neuromuscular weakness."
"What is the primary treatment for nocturnal alveolar hypoventilation in OHS patients?"
"Positive Airway Pressure (PAP) Therapy, including CPAP or BiPAP, is mandatory to treat nocturnal alveolar hypoventilation and correct co-existing OSA."
"Explain the importance of weight reduction in the management of Obesity Hypoventilation Syndrome."
"Significant, sustained weight loss is essential to reduce mechanical chest wall loading and improve respiratory function."
"What substances should patients with OHS avoid to prevent further depression of ventilatory drive?"
"Patients should completely avoid alcohol, sedatives, and hypnotics."